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In this study several machine learning approaches were compared to the accuracy of more tradi-
tional ways of predicting the effect of a dose of Warfarin, an anticoagulant, in heart-valve transplant
patients. The twin motivations for this project derived from its potential contribution to the field
of time-series machine learning, as well as the medical applications. A new ‘two-layer’ approach
was attempted to account for the fact that the Warfarin problem consists of multiple, potentially
related data-sets. Many different attribute combinations were attempted to provide the best rep-
resentation of the data and any temporal patterns observed that could help with prediction. Its
value in a medical sense derived from the desirability of an accurate web-based system with which
self-management of patients could be facilitated. Machine learning was considered a viable solu-
tion to the difficulty of Warfarin dose prediction as machine learning algorithms endeavour to cope
in a heuristic manner with problems in real data sets such as non-linearity and noise. When tested
on the data of heart-valve transplant patients, it was found that the effect of a Warfarin dosage
could be predicted with the most accuracy by machine learning algorithms learning on the history
of multiple patients. However, the best performing algorithm and attributes differed from patient
to patient, making a one-fits-all solution unlikely. The potential for machine learning solutions to
out-perform physicians was demonstrated, meaning further work to increase their accuracy would
be recommended in this area.
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Predicting the effect of the drug Warfarin, an anticoagulant, is a difficult and risky task. It is hoped
that a machine learning solution may be able to improve on the current level of accuracy achieved.
The field of machine learning evolved out of Artificial Intelligence in the late 1970s (Briscoe &
Caelli 1996), with the first practical algorithms of ID3 (Quinlan 1986) and AQ11 (Michalski &
Larson 1978). It is a branch of computer science that deals with constructing models based on
known data, in order to explain its structure or variability, usually for the purpose of classifying
or predicting the value of future data. The machine learning system usually produces either an
equation, a set of rules or a decision tree, which can be used to explain and predict the data.
Data Mining is a closely related field, in that it can be defined as the extraction of previously
unknown relationships from a data-set, often in order to predict future data values. machine
learning investigates ways in which the extraction of these relationships can be automated in an
efficient and accurate manner. Machine learning has an advantage over pure statistical methods,
in that its different algorithms endeavour to cope with issues such as nonlinearity, noisy data and
a lack of prior knowledge of the domain, albeit with varying degrees of success. Most machine
learning algorithms work by following heuristics to allow them to efficiently search a set of hy-
potheses that may explain the data in order to find a good hypothesis in an acceptable length of
time.
One approach favoured by some algorithms is that of instance-based learning, where the known
example with attributes most similar to those of the given example is used to predict other
information about the given example. Neural networks and genetic algorithms have also been
developed, to simulate the reasoning of the human brain and the ‘survival of the fittest’ idea of
evolution, respectively. However, the main drawback of neural networks is their inability to explain
the structure of the data, even if they can often predict the value of an attribute of a given example
accurately (Witten & Frank 2000). This lack of reasoning behind a particular classification can
also be said of some of the results derived from instance-based learning.
There has been a growing interest in machine learning as its potential and successes in a
variety of applications has become recognised. It has been successfully applied to a variety of
domains, including both identifying and classifying astronomical bodies (Langley & Simon 1995)
and helping epidemiologists understand the dynamics of tuberculosis epidemics (Getoor, Rhee,
Koller & Small 2004). Recent research has been interested in applications of machine learning to
time-series domains. Time-series domains can be defined as those applications where the history
of the data can be used to predict future values. One difficulty with the data of such domains is
that any attempts to model this history in a form such that it can be used to predict the future
can result in data-sets with enormous numbers of attributes. Large volumes of real-world data are
required to test and assess the various methods of modelling time-series data. These real world
data-sets would have properties of that make machine learning difficult, namely noise, irrelevant
attributes, and missing data.
The Warfarin data-set represents a time-series problem as it examines the different dosages
and INR values recorded for a patient over time. It also contains all the properties mentioned
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in the previous paragraph. Noise is inherent in the data-set as it is impossible to control a
patient’s life-style, so confounding factors, including non-compliance with their Warfarin therapy,
are extremely likely. Other errors or missing data derive or arise from the fact that the data have
been obtained from hand-written doctor records of a patient. Errors when performing data-input
are also possible. It is therefore ideally suited as a data-set to examine time-series data with
machine learning. In this problem, the history of dosages for heart-transplant patients is known,
along with the corresponding International Normalised Ratio (INR), which measures the time the
blood takes to clot and can be compared both between patients and across different countries.
From this, it is hoped some machine learning algorithm will be able to predict either the effect of
the next dosage on the INR, or the optimal next dosage for a particular INR reading, with some
degree of accuracy.
1.1 The Importance of Correct Warfarin Prescriptions
The development of an accurate method for calculating Warfarin dosages is crucial, both because
of the potential danger to the patient if the dosage is incorrect, and because of its wide use, with
13,891,000 prescriptions filled in 2003 in the United States alone (Marketos 2004). Warfarin is
taken by heart-valve transplant patients as a blood-thinner, because after such operations there
is a very real danger of blood clots occurring on the heart-valve. Currently 6,000 patients in
the United Kingdom and 60,000 in the United States undergo heart-valve transplants every year
(Bloomfield 2002). A safe Warfarin dosage range, defined as being when the INR reading is within
some target range, endeavours to minimise the chance of clotting, while still ensuring the patient
has enough clotting ability so that he or she does not bleed to death.
Incorrect Warfarin dosages can have a drastic effect on a patient as Warfarin has a very narrow
therapeutic index. The target INR range differs depending on the type of valve replacement, and
to some degree also on the patient. A target INR range of 2-3 is generally recommended, but
for bileaflet mechanical valves in the aortical position, this range is usually even more precise, at
2.5-3.0. For bileaflet valves in the mitral position, a range of 3-3.5 is usually targeted, whereas for
other heart-valves, an INR reading between 3.0 and 4.5 is desired (Bloomfield 2002).
However, studies show that only 50-75% of INR readings are likely to fall into the desired range
for a particular patient (Gallus, Baker, Chong, Ockelford & Street 2000). Between 1.1% and 2.7%
of patients managed by anti-coagulant clinics suffer major bleeding (Gallus et al. 2000). Warfarin
therapy mismanagement can also have a large financial impact, shown by the case in 2002 where
a Philadelphian hospital was sued for US $447,500 after the deaths of three patients were linked
to overdoses of Warfarin (American Medical Association 2002).
1.2 Why Accurate Warfarin Dosing is Difficult
Determining the appropriate dosage of Warfarin is extremely difficult for many reasons. One of the
most important reasons is the way in which the drug effect is measured. Warfarin has a half-life
of 36 hours (Gallus et al. 2000), so it takes approximately 4-6 days to achieve new steady-state
plasma concentrations after dose adjustments. Furthermore, the anticoagulant response monitored
is only an indirect measure of the drug’s actual effect, which is to reduce the ability of the body
to make the prothrombin complex necessary for blood clotting (Roland & Tozer 1995). For these
reasons, the maximum response to a dose is not visible for at least one or two days after ingestion,
making it difficult to accurately adjust the last dosage given after a worrying INR reading.
Furthermore, there is a large variance in individual responses to the drug due to its complex
pharmacology (Gage, Fihn & White 2000). The response of an individual to a particular dose is
affected by many factors. These include an individual’s age, weight and gender, lifestyle habits
such as alcohol and tobacco consumption, and even environmental factors. Patient compliance is
also an issue, as is some acquired tolerance for Warfarin (Roland & Tozer 1995).
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The general health of the patient can also affect one’s response to Warfarin, a factor of par-
ticular importance as most Warfarin consumers are elderly (Gallus et al. 2000). For example,
acute viral hepatitis causes excessive anticoagulant response, so less Warfarin should be prescribed
(Roland & Tozer 1995).
Another concern for elderly patients is that Warfarin interacts with a variety of other medica-
tions and foodstuffs. It is sensitive to vitamin K intake, and hence may be affected by foodstuffs
high in this, such as green tea, lettuce and broccoli (Northwestern Memorial Hospital 2003). Any
changes to the way in which Warfarin is formulated also affect the required dosage; a study per-
formed on the generic substitution of Warfarin formulations in 1998 in the United States, where
Warfarin brands were replaced by a generic formulation, discovered that apparent sensitivity to
Warfarin in all patients decreased (Halkin, Shapiro, Kurnik, Loebstein, Shalev & Kokia 2003).
The genetic makeup of an individual has also been shown to be a factor. A regression model has
been built taking into account the phenotype (observed nature) of the CYP2C9 gene, responsible
for metabolising a wide range of drugs including Warfarin. Along with age, weight and gender,
this model was able to explain up to 40% of variability in Warfarin response (Michaud, Morin,
Brouillette, Roy, Verret, Noel, Taillon, O’Hara, Gossard, Champagne, Vanier & Turgeon 2004).
In addition, cytochrome P450 genetic mutations have been shown to account for most of those
patients who require very small dosages of Warfarin (Joffe, Xu, Johnson, Longtine, Kucer &
Goldhaber 2004).
The complex nature of these factors and how they interact, along with the impossibility of
accurately measuring them for a particular patient, means that accurate Warfarin dosage has
proved to be very difficult. Time-series machine learning analysis could help, however, as it is
hoped that a patient’s history would implicitly represent those factors affecting their response to
Warfarin. If such a history could be appropriately modelled, it could be used to predict the current
dosage instead of explicitly attempting to model individual factors. An automated model would
also be desirable if it were sufficiently accurate, in that it would allow patients to adjust their own
dosage based on self-testing, from their own home, through a secure Internet server. More detail
on the benefits of this is found in Chapter 3.
In Chapter 2, we first describe the current state of research into time-series domains of machine
learning. Current methods for calculating Warfarin prescriptions, including any involving machine
learning, along with any research into improving these, are also detailed in Chapter 2. Chapter 3
contains the aims of this research project. Chapter 4 provides an explanation of the different ways
in which the patient’s history will be represented, along with a rationale for and description of
the various algorithms experimented with. Results from experiments on actual patient data and
a discussion of these are shown in Chapter 5, followed finally by what has been learned from this
research and opportunities for further research.
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Relevant research with regard to this project can be divided into two main areas. Firstly, as
the Warfarin data-set is an example of time-series data, one must examine how machine learning
algorithms are currently being applied to time-series data in a variety of domains. There also exists
a body of research that attempts to improve Warfarin dosage accuracy, through either automated
or other methods. Previous attempts to apply machine learning to the Warfarin problem are
discussed here.
2.1 Machine Learning and Time-Series Data
Time series data differ from other forms of data in that there are likely to be potentially useful
relationships between different attributes, because the attributes are just instances of the same
data. Some specific new algorithms have been developed in an attempt to compensate for the
propensity of most machine learning algorithms to ignore these. In Kolarik & Rudorfer’s (1994)
study, a back-propagation neural network with one hidden layer was used to model time-series
data. However, the number of hidden units to be used must be experimented with to find a
number suitable to the data set. The best results were achieved by performing a logarithmic
transformation on the time-series data beforehand, after which the neural network outperformed
traditional regression tools. For this reason neural networks will be trialled for the Warfarin data
set.
Another algorithm, developed by Geurts (2001), works by using regression trees to model piece-
wise functions to represent temporal signals. Geurts (2001) argues against the use of traditional
machine learning algorithms for temporal data, arguing their use sacrifices interpretability of clas-
sification rules. He also argues that some temporal rules cannot easily be represented traditionally,
giving the example of trying to discover a rule which asks for three consecutive values to be within
a certain amount. However, it is not certain that his solution would be suitable for the Warfarin
problem. Firstly, this method did not achieve better results than näıve sampling when tested on a
data set with more than one attribute. The Warfarin problem fits into this category, as every data
point has an INR value and a dosage, as well as existing at some point in time. Furthermore, the
algorithm was not convincingly verified on real data, with two out of the three datasets on which
the algorithm is tested being artificially developed for research in this context. Their method of
analysing the success of the algorithm was also questionable because cross-validation was used.
With cross-validation, a random subset of the data is extracted, and the rest used to train the
algorithm. This will most likely be repeated several times, with a different subset of data selected
for testing each time. This means that for a data-point n in the testing set, it is quite likely that
values of the patient history that occurred after n will be used to train the algorithm that then
predicts the value for n. In Geurts’s (2001) study, the accuracy with which this n can be predicted
in such a way is being used as a statistical measure of the accuracy of the algorithm. When using
data from a patient history to train a model, future data cannot be used to help the doctor decide
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how much to prescribe at the current time. This means that the only way to measure the accuracy
of a machine learning technique in this case is to look at the number of successes it achieves in
predicting a data point after being trained only on a history of the data-points preceding it.
Other suggested methods for temporal data include that of Kadous (2002), who attempted to
first extract ‘metafeatures’ from a temporal data series, and then train different machine learning
algorithms on this. This is principally used, however, for finding similarities between behaviour
of a certain value during two different spans of time, in order to classify such spans of time.
Nevertheless, this means that if a span in time can be classified correctly, the value of individual
points within this can be derived. It also attempts to use global attributes (such as gender in our
domain) and aggregate features (attributes derived by combining other attributes). However, a
major drawback is that again it only really looks at the value of one attribute over time, and in
our domain we have two, namely INR and dosage, which are related to each other. It also does
not outperform base-line methods on the two data-sets on which it was tested, and fares badly
under noise.
Hidden Markov Models are the usual method for performing time-series analysis, and a novel
approach combining these with providing reward notification on correct behaviour was developed
by Wierstra & Wiering (2004). This was tested on datasets with more than one attribute for each
data point in the past. It is designed to be suited to stochastic and noisy environments. However,
these were not considered to be so useful for this domain, being useful more in domains such as
speech recognition. Hidden Markov Models rely on gaining a large amount of state information
from the history. Although values immediately surrounding each data-point do have some influence
on the value of the current data-point, this domain does not really seem to have recurring chains
of values from which further values along the chain can be predicted.
A recent survey on new methods for modelling time-series data was performed by Keogh &
Kasetty (2002). This evaluated 56 papers, and considered all to be lacking in several key areas.
The main problems were that they were tested on a mean of 1.85 data sets, and hence were not
proved to be widely applicable, and secondly were usually only compared to one other algorithm.
In our study it was hence deemed necessary to try and use multiple data sets where possible, albeit
for the same domain. It must be remembered however that the primary aim is not to determine
a generic time-series solution, as different algorithms are suited to different domains; instead, the
best solution for the Warfarin time-series data is desired. Many different algorithms will also be
examined to avoid the problems of lack of comparative information found in other studies.
2.2 Current Methods for Warfarin Dosage
It is important to examine current Warfarin prediction methods, firstly as they may offer insight
into a machine learning solution, particularly with regard to attributes selection, and secondly as
a means of comparison. Warfarin is currently prescribed in a variety of different ways. Although
computer support is beginning to be recognised as useful, many clinics and physicians still use
paper-based nomograms or loading tables.
2.2.1 Non-computerised dosage calculation
The simplest mechanism for prescribing Warfarin is a “loading table” of rules specifying what
dosage is needed following a given INR reading. This, however, does not acknowledge individual
differences in Warfarin response. Current advice is to adjust the dosage by 5-20% of the total
weekly dose, depending on the current INR, the previous dose, and any reasons identified that
might explain the undesirable current INR reading (Jaffer & Bragg 2003, Horton & Bushwick
1999). Other policies also exist for determining whether the INR is such that the dosage should
be changed. These include altering dosage either after two consecutive out-of-range INR readings,
or if the INR reading exceeded the target range by a given amount. An example of a loading table
used by some physicians for dose adjustment is shown in Table 2.1.
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INR Goal 2.0 - 3.0 INR Goal 2.5-3.5 Action
≥ 6.3 ≥ 6.3 Stop Warfarin, evaluate for bleeding and
call physician
4.5 - 6.2 4.5 - 6.2 Stop Warfarin for 1-2 days, then decrease
total weekly dose by 20%.
Repeat INR in 1 week.
3.6-4.4 4.1-4.4 Decrease total weekly dose by 15-20%.
Repeat INR in 1-2 weeks.
3.2-3.5 3.7-4.0 Decrease total weekly dose by 10-15% or
maintain same dose.
Repeat INR in 1-2 weeks.
1.9-3.1 2.4-3.6 No change. Repeat INR in 1-2 weeks.
If stable patient (2 consecutive goal INRs)
repeat INR in 3-6 weeks.
1.3-1.8 1.6-2.3 Increase total weekly dose by 10-15%.
Repeat INR in 1 week.
< 1.3 < 1.6 Increase total weekly dose by 15-20%.
Repeat INR in 1 week.
Table 2.1: Warfarin dose adjustment protocol used by Clarian Health Family Practice Centre
Anticoagulation Clinic (Clarian Health 2004)
Graphical “nomograms” have also been developed to help with dose adjustment, such as that
by Dalere (1999) shown in Figure 2.1. This was developed by first constructing a model of
Warfarin activity (using pharmacodynamic and pharmacokinetic variables), and then plotting the
expected behaviour of the INR for certain values of these variables when the dosage is varied.
The pharmacodynamic variables were then varied to produce other curves, to try and model
individual responses to Warfarin. The nomogram is used by finding the curve on which the
current INR reading and dosage lie, and following this curve until the desired INR reading is
reached. At this point the desired dosage can be found by reading the matching value on the
x-axis. A study was performed on 111 patients, divided into three groups depending on whether
their Warfarin treatment was to be managed by this nomogram, an experienced physician or the
Bayesian Regression computer programme described in Section 2.2.2. This showed the nomogram
to be significantly better than other methods when the mean amount of prediction error was
compared. However, this paper did not give the percentage of time during which the patient was
in range, making further comparisons difficult.
In general, success rates for physicians, using either nomograms, dosage adjustment tables
or their own experience, have not been particularly high. A study by Schaufele, Marciello &
Burke (2000) demonstrated this by analysing 181 patients receiving Warfarin treatment over a
four-month period through a rehabilitation centre. Only 38% of all INR readings were found to be
within the target range. Most physicians, however, achieve a 50-75% success rate for a particular
patient (Gallus et al. 2000). This is still relatively low, especially when combined with the fact
that between 1.1% and 2.7% of patients managed by anti-coagulant clinics suffer major bleeding
(Gallus et al. 2000).
2.2.2 Current Technological Support
The potential of computer support for Warfarin dosage has been recognised by many researchers.
It is hoped it may improve accuracy of dosage, cut costs, decrease physician workload, increase
convenience for patients and help with keeping an accurate patient medical history. Originally the
potential of computers was limited to making recommendations of dosage using a formula derived
by clinicians, such as in the system developed by Wilson & James (1984). Twenty years after the
development of this system, the real potential for computer support is still being ignored by some,
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Figure 2.1: Graphical nomogram for prescribing Warfarin
with the development of similar systems simply calculating results using theoretically calculated
algorithms. An example of such a system developed in 2003 was that developed by Kelly, Sweigard,
Shields & Schneider (2003) for patients taking Warfarin after knee or hip replacement surgery.
Their Virtual Anticoagulation Clinic was supervised by a specifically trained nurse or assistant
who monitored patients and followed clinical decisions, especially important from a safety point of
view. Warfarin dosage was recommended based on some theoretically calculated clinical decision
support algorithms. This was achieving ‘safe’ INR values 70% of the time for its 1,928 patients
a year after the system was first implemented. However, this system made little attempt to
individualise dosage recommendations for a given INR reading. Computerised pharmacokinetic
and pharmacodynamic models and simulations have also been used, achieving at least similar, if
not better, accuracy than manual dosing when examining the amount of time spent in range by
the patients (Vadher, Patterson & Leaning 1997, Abbrecht, O’Leary & Behrendt 1982, Ageno &
Turpie 1998). The BAP-PC computer decision support system, which has been used in the United
Kingdom by many primary care centers since 1998 and implements the “Coventry Model”, achieved
a mean of 58% of in-range INR readings (Oppenkowski, Murray, Sandhar & Fitzmaurice 2003). A
survey of three currently-used computerised systems showed them to be particularly effective when
patients had a higher than usual INR target range, as physicians tended to be too conservative
and under-dosed their patients (Poller, Wright & Rowlands 1993).
The computational power of computers has also been exploited in several systems using
Bayesian probability. One of these uses a Bayesian forecasting model to try and reach a ther-
apeutic Warfarin level after total hip arthroplasty, and found a significant improvement in the
computer-assisted group (Motykie, Mokhtee, Zebala, Caprini, Kudrna & Mungall 1999). Another
computer system implemented Bayesian regression with some success (Svec, Coleman, Mungall &
Ludden 1985), but when tested against the graphical nomograms discussed above in Section 2.2.1,
produced worse results (Dalere 1999).
A unique addition to the literature on anticoagulant management was research by Good, Hahn,
Edison & Qin (2002). This used a run-to-run control algorithm used typically for semiconductor
manufacturing and achieved good results in maintaining a patient in its desired therapeutic range.
However, significant input by physicians is necessary to determine whether an unexpected response
to a dosage is the result of a temporary aberration or a permanent lifestyle change.
12
2.2. CURRENT METHODS FOR WARFARIN DOSAGE
Machine Learning Solutions
There have been some attempts to utilise the machine learning capabilities of computers in War-
farin treatment. The worth of machine learning has been proved in the prescription of other drugs,
as shown in a study by Floares, Floares, Cucu, Marian & Lazar (2004), where neural networks
were used successfully to compute an optimal dosage regimen for chemotherapy patients. These
produced better results than the other conventional or artificial intelligence approaches reported
in the study.
Mayo (2002) researched machine-learning solutions to Warfarin drug prescription, but there
were some concerns with the conclusions reached. Firstly, all data came from one patient, and
moreover did not take into account that this patient was growing from adolescence to adulthood.
Additionally, it is never made clear whether the success rate claimed is from testing on new data,
or is just an indication of how well the machine learning model fitted the training data. The
attributes and machine learning parameters used were also not precisely specified.
Narayanan & Lucas (1993) also attempted a machine learning solution to predicting INR
levels after a given dosage, by using a genetic algorithm to select variables with which to train
a neural network. However, no comparisons were offered to other solutions, examining only the
benefits of the genetic algorithm addition to the existing neural network. Neural networks have
been investigated by Byrne, Cunningham, Barry, Graham, Delaney & Corrigan (2000) and found
to be twice as accurate as physicians at predicting the result of a given dosage. The benefits
of extracting rules for Warfarin dosage from ensemble learning have been researched by Wall,
Cunningham, Walsh & Byrne (2003). It is hence hoped that these and other machine learning
techniques will be able to perform well in predicting the effect of a given Warfarin dose for a
particular patient in our study.
Self-management of Warfarin
There has also been some recent research, with the development of computerised solutions to
Warfarin prescription, into the benefits of letting the patient use such systems from their own
home. Self-management of Warfarin, allowing INR measurements to be taken and the dosage
adjusted more frequently, has been proved by Sidhu & O’Kane (2001) to result in a patient’s INR
reading being within the desired range 76.5% of the time. This is significantly different from the
63.8% accuracy achieved for patients managed conventionally. Many other studies have confirmed
these findings, such as that by Cromheecke, Levi, Colly, de Mol, Prins, Hutten, Mak, Keyzers &
Buller (2000), which showed self-management to perform at least as well as specialist management
clinics, and resulted in greater patient satisfaction. Surveys of studies by Hirsh, Fuster, Ansell &
Halperin (2003) and Ansell, Hirsh, Dalen, Bussey, Anderson, Poller, Jacobsen, Deykin & Matchar
(2001) showed this to be a general trend.
However, in many of these self-management trials, including that by Sidhu & O’Kane (2001),
only a very simple protocol was used by patients to adjust their Warfarin dose (Table 2.2. Sidhu
& O’Kane (2001) also observed that not all patients could be successfully trained to manage their
own therapy, and only two-thirds of those successfully trained were able to manage their own
anti-coagulation for a period of two years. It is hoped a computerised system would enable more
patients to self-manage their dosage regimes, and hence capitalise on the advantages of frequent
measurement. It would also hopefully be more accurate than the simple protocol used here.
INR Value Obtained Action Taken by Patient
< 1.5 Contact doctor for advice
1.5− 1.9 Increase dose of Warfarin by 1 mg daily
2.0− 2.5 Same dose of Warfarin
2.6− 4.0 Decrease dose of Warfarin by 1 mg daily
> 4.0 Contact doctor for advice
Table 2.2: Protocol used in Self-Management Patient Study (Sidhu & O’Kane 2001)
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The main goal of this research is to find the machine learning solution that can predict the result
of a given Warfarin dosage with the greatest accuracy. This involves examining different attribute
selection, using different algorithms, stratification of data and a novel two-layer approach, discussed
in Section 4.2.3.
It is then an aim of this study to compare this best solution with the accuracy of the physician
for the patients used in this study, that of a graphical nomogram technique, and in a general sense
with the accuracy reported in the literature.
Another ambition of this research is to examine the Warfarin problem in the context of time-
series data. An interesting feature of the Warfarin problem is that there are multiple related
data-sets available, all with more than one attribute for each data-point. Current time-series
research, as detailed in the previous chapter, focusses on understanding a sole data-set, usually
containing the value of only one attribute over time. With the Warfarin problem, both the reaction
of a patient to previous doses as well as the reaction of other patients to Warfarin doses might
help with prediction. This could be particularly important when the patient does not have a long
history of taking Warfarin. In this research the effect of other patient histories on predicting the
dosage for a particular patient is hence to be examined.
Furthermore, accuracy is not the only attribute of a final machine learning solution that should
be considered. A crucial part of the motivation for this project is to prove the viability of a web-
based system based on the results of this research. It is hence important that the solution be one
that can be calculated relatively quickly. It also must not require expert input once it is running,
although some monitoring would be undertaken as a safety precaution. This would improve on
current patient self-management detailed in the previous chapter as it would be able to adjust
dosages based on individual responses to Warfarin, and also decrease stress for the patient as
they would not have to be solely responsible for deciding how to change their dosage. A study
published by Walker, Machin, Baglin, Barrowcliffe, Colvin, Greaves, Ludlam, Mackie, Preston
& Rose (1998) delineated some guidelines for Warfarin dosage computer systems, and should a
solution derived from this research ever be implemented in a clinical trial, these would have to be
followed. These specified that the computer needed to alert trained staff should patient INR levels
be dangerously high or low, or should the patient stop checking their INR, and allow clinicians to
override computer recommendations.
Even should the system be used in clinics in conjunction with physicians rather than as a web-
based service, this would still be useful in providing recommendations to doctors, especially those
less experienced with Warfarin dosage. The physician could adhere to or override this dosage if he
or she felt it necessary. It would also be valuable in giving physicians more confidence to prescribe
higher doses, as has been shown in previous studies involving computer support (Walton, Dovey,
Harvey & Freemantle 1999).
It is to be noted that in this research we will be examining the ability of a solution to predict
the effect of a given dosage of Warfarin. Although it will not therefore give a recommendation
on what Warfarin dose should be prescribed, should it be sufficiently succesful at predicting the
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effect of dosages, it should be relatively simple to extract a range of values that is expected to give
a safe INR reading. From this, a mid-point or similar can be offered as a recommended dosage.




Some visualisation and simple regression on patient data were first undertaken to see whether the
effort of a machine learning solution was worthwhile. There seemed to be low correlation between
the INR levels and corresponding dosages, with a Pearson correlation factor ranging from 1% to
68% for different patients. This made it more likely that a non-linear solution would be needed.
Following this, several steps had to be followed to try to find a suitable machine learning
solution.
• Decide what the machine is to be trained to predict (the ‘Learning Task’)
• Choose the data set and how it is to be used
• Select different machine learning algorithms for trialling
• Select the attributes to model the patient and patient history
• Run experiments
• Perform comparisons
Before full experiments were run on patient data, many machine learning solutions were briefly
investigated. This involved researching possible candidate algorithms, performing small trial runs
on data subsets and estimating which algorithm parameters might give the best results. The
WEKA tool-bench (Witten & Frank 2000) was used as a source of implementations of all algo-
rithms considered.
4.1 The Learning Task
Two options immediately presented themselves when considering the form that the output from
the machine learning algorithms should take. The first of these was a numerical value of the
expected INR reading after a given Warfarin dosage. However, this severely restricted the number
of machine learning algorithms that can be used, because the vast majority of machine learning
algorithms produce a nominal classification as their output. Since the actual value of INR is less
important than its relative position to the therapeutic index, it was decided that the end result
of a particular Warfarin dosage could be usefully classified as either “low”, “in range” or “high”.
The discretisation of real values into nominal values is known as ‘binning’.
4.2 Possible Approaches
Several approaches were proposed as possible solutions, within which different algorithms and
attributes could be used. These approaches principally differ in the source of data used for training
17
4.2. POSSIBLE APPROACHES
the system as well as whether some form of ensemble learning is to be used. These vary from
learning from one’s own history, to learning from a vast data-set comprising everyone’s history, to
learning using the ‘Two layer’ approach detailed below in Section 4.2.3.
4.2.1 Learning from One’s Personal History
The simplest solution possible would be predicting a patient’s response to Warfarin solely by
examining this patient’s history of interaction with the drug. This would have the advantage that
any model of the patient built by the machine learning algorithm would be individualised as much
as possible for that patient. However, this solution would obviously not be ideal if the patient did
not have a long history on which the algorithm could train itself. This is the most difficult time
of prediction for human physicians as well, and is also a more dangerous time for the patient.
4.2.2 Learning from Multiple Patients’ Data
Alternatively, data from all patients could be used to train an algorithm, from which predictions
for an individual patient could be made. In such a system, any data point, no matter to which
patient it belonged, is used by the algorithm. This would have the advantage that the algorithm
could be used to predict data points for a patient when the patient’s own history was very small.
It would also possibly add accuracy to predictions if dealing with an INR value that was poorly
represented in the history of this particular patient but had occurred more often in the general
population. However, it has the disadvantage that the data from other patients may not in fact
be useful when considering the patient under study.
4.2.3 An Ensemble Approach using Multiple Patient Data
A ‘Two layer’ approach has been trialled in this study as a variation on the types of ensemble
learning often practised in machine learning. Ensemble learning is where the results of independent
or iterative learning procedures are combined in some way to obtain a final result. In this case,
ideas from two popular ensemble learning techniques, ‘bagging’ (Breiman 1996) and ‘stacking’
(Wolpert 1992), were combined. Bagging typically splits up one dataset into random subsets, and
trains individual machine learning algorithms on each subset. Stacking is where the outcomes of
multiple machines trained on the same data are passed through a second machine, which learns
to predict a final classification based on the predictions of these machines.
In this case, individual learning algorithms were applied to the datasets of different patients.
Hence each patient’s history, including that of the patient currently under study, was modelled
separately. The algorithms and attributes chosen for each patient were those that performed best
after experiments on learning from only that patient’s personal history. Following this, each patient
model was given the same data-point, and their predictions of the resultant INR level for this data-
point fed into the ‘second-layer’ algorithm. This was then trained to use these predictions as a
means for predicting the real INR value for this patient. The second-layer algorithm was varied to
try to improve performance, trialling most of the candidate machine learning algorithms detailed
below.
A representation of this system can be found in Figure 4.1.
It must be kept in mind, however, that if one is predicting the INR value for data-point n of
a certain patient, only data-points which occurred before this data-point in time could be used to
train the machine learning algorithm building the patient model for this patient. All data-points
could be used to train the other patient models, however, as there is no temporal interaction
between patients.
It was hoped that this approach would achieve a good success rate as it combined the desirable
attributes of the other approaches previously outlined. It was hoped that the use of multiple
models would minimise the chance of error as the ‘opinions’ of multiple machines were being
sought before a final prediction is made. It also adapted to an individual patient, yet used the
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Figure 4.1: The ‘Two layer’ approach
data of the whole population to help it make predictions for INR values that were rare for the
individual patient.
Elements of ‘bagging’ can be seen in that the data set of multiple histories is divided among
different algorithms, but in this case the division of data-points is done in an ‘intelligent’ fashion,
depending on to whom they belong. Similarly, the idea of a second machine, learning on the
results of a first layer of machines, derives from the ‘stacking’ concept.
4.3 Candidate Machine Learning Algorithms
Most Machine Learning algorithms can be classified as being either instance-based, rule-based,
neural networks, genetic algorithms, or hybrids of these approaches. Representative algorithms
from each of these were trialled, along with two algorithms that are harder to classify in such
a manner, namely Support Vector Machines (SVM), which is in fact based on regression, and
Fuzzy Lattice Reasoning (FLR). All algorithms mentioned in previous research were tested. The
machine learning algorithms below were all trialled for both the case of learning only from one’s
own data, and learning from multiple patients’ data.
4.3.1 J4.8
J4.8 is the last public version available of the C4.5 top-down decision tree learner. This is a
variant of ID3, which determines at each step the most predictive attribute, and splits a node
based on this attribute. Each node represents a decision point over the value of some attribute.
J4.8 attempts to account for noise and missing data. It also deals with numeric attributes, by
determining where thresholds for decision splits should be placed. In our domain, this might see
a node split according to values of the attribute “currentDosage”, stating if it is below a certain
value to follow a particular branch of the decision tree, otherwise to follow the other branch. The
end result is a set of rules obtained from the decision tree, with some pruning of rules that are
more complex than necessary. Rules are pruned in an attempt to combat noise, and so the rules
learned do not over-represent the training set. In this way disjunctive rules can be learned, where
different combinations of attributes may give the same classification.
The main parameters that can be altered for this algorithm are the confidence threshold, the
minimum number of instances per leaf and the number of folds for reduced error pruning. This
last variable is only relevant if reduced error pruning is to be used, instead of trying to make
an error estimate based on the training data. The algorithm was trialled with the default values
of 0.25 and 2 for the first two of these. Reduced-error pruning was not used since it works by
dividing the data set into the number of folds for error pruning. All these subsets except one are
then used for training, and the subset that is left out is used to validate the generated rules when
transforming the tree into a rule set. With small patient histories, such as when we are predicting
early data points, this may result in only two or three data-points being used to validate the rules.
In addition, it leaves less data available to build the tree.
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It was hoped this algorithm would be useful as it has been successful in many domains, and it
has been designed to cope with problems such as noise. Its rule-based nature also means that it
provides explanations for its decisions, something which may have given physicians more confidence
in its predictions.
4.3.2 Non-Nested Generalised Exemplars (NNge)
This algorithm also generates rules for classification of a data set. However, it derives from
instance-based approaches as it works by placing instances from the data-set into an instance
space, and then tries to generalise groups of instances into rules. This algorithm was implemented
firstly in its default form, but also with a limit of ten placed on the number of neighbours it
will examine to attempt to generalise from. This causes the algorithm to try harder to make
generalisations, but may make it more vulnerable to noise.
It was hoped that NNge would be useful as it is designed to avoid the specificity bias and hence
potential over-fitting of Nearest Neighbour(IBk), as it generalises the data. It has been proved
in some situations, normally those with both large and small disjuncts, to outperform J4.8 and
nearest neighbour. It also reduces classification time, important in a web-based system. However,
current implementations are somewhat vulnerable to noise (Martin 1995).
4.3.3 Nearest Neighbour (IBk)
Instance-based learners are ‘lazy’ classifiers, in that they delay the effort of classifying data until
test instances are actually given. For every test instance, its similarity to other instances is
calculated, and the classes of the n most similar instances are used to predict the class of the test
instance. Three different variations of IBk were used. Two of these used three neighbours for
classification to try to reduce the effect of noise, which is likely to adversely affect classification
accuracy if only one instance is used. In one case, the neighbours were weighted by the inverse
of their ‘distance’ from the test instance, so that closer instances had more influence over the
classification of the test instance. The third variation used this inverse weighting, but over the
five nearest neighbours. However, high values of n are clearly not desirable with small data-sets,
as then the n-nearest neighbours may in fact be so different as to be completely irrelevant. The
inverse weighting assists in this regard, as any neighbours that are in fact too disparate will have
very low weight.
Instance-based learning is simple, independent of the order in which examples are given to
the algorithm, and often works well. The success rate of this algorithm may suffer, however,
for attribute values that are sparsely represented in the data-set, particularly a problem when
classifying early values in a patient’s history.
4.3.4 Ripple-Down Rule Learner (Ridor)
Ridor is another algorithm that produces a set of rules. It works by generating a default rule, after
which exceptions are generated in a tree-like fashion. This has been used with success in large
databases previously, such as those containing patient information used for diagnosing thyroid
disorder (Gaines & Compton 1995).
4.3.5 Repeated Incremental Pruning to Produce Error Reduction (RIP-
PER)
This algorithm, proposed by Cohen (1995), was only used in the implementation of the two layer
approach as a second-layer algorithm, in an attempt to find an algorithm that would increase
the system’s accuracy. The algorithm starts off with an empty rule-set, and ‘grows’ a rule by
adding conditions until the rule is perfect. It then incrementally prunes rules to avoid over-fitting,
optimises and sometimes deletes rules.
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This algorithm was trialled since Cohen’s (1995) paper showed RIPPER to be efficient on noisy
datasets and to often achieve higher accuracy than C4.5, the decision tree learner on which J4.8
is based.
4.3.6 Genetic Algorithms
Genetic algorithms follow the basic idea of starting with a series of hypotheses, modifying each
generation of hypotheses to generate new ones, while maintaining in a probabilistic fashion the
most promising from the old generation, and stopping either after a certain number of generations
or when the success level of a hypothesis reaches some predetermined threshold.
In the WEKA suite, genetic algorithms are only available when implementing Bayesian Network
classifiers, as it allows one to find an optimal network using a genetic algorithm search. These were
run twice, with varying parameters. The initial case had an initial population size of 100, with
200 descendants and ran for 50 runs with cross-over and mutation of hypotheses allowed. The
‘fitness’ of a particular hypothesis was judged using a Bayesian metric. A more complex version
of the algorithm had an initial population size of 1000, with 2000 descendants and ran for 500
generations. This is supposed to increase the likelihood of finding the best network structure, but
may in fact take too much time to be viable. However, it must be remembered that this time is
only taken during training, and not classification, so this may not be too problematic. This would
be true even in the case of an Internet system, as training can be performed while the patient is
offline. With this network, an estimator must also be specified from the two options available, and
the ‘Simple Estimator’ was used in both cases. These calculate the conditional probability tables
for the network (Bouckaert 2004).
4.3.7 Neural Networks
Neural networks derive from attempts to simulate the theoretical workings of the human brain.
Artificial neural networks consist of layers of perceptrons, which consider weighted inputs and
based on these give a single output. Backpropagation is a valuable addition to neural networks,
featuring a supervised mode of learning and a feedforward architecture (Hussain & Ishak 2004).
Supervised learning means that weightings of connections are adjusted according to the accuracy
with which the existing network classifies the input, so the network is trying to match the output
with a known target value. The reference to a feedforward architecture simply means that output
from the input layer becomes the input to the next layer, and so on. Changes to weights, deter-
mined from discrepancies between the actual and desired output, are ‘backpropagated’ from the
output layer to the previous layer, which in turn feeds the adjustments back until the first layer
is reached.
However, neural networks are typically somewhat of a ‘black box’ approach in that they do not
help understanding of the domain to any great extent, and often find a locally optimum solution
rather than a global best solution. Despite this, it is hoped that their expressive nature and ability
to learn very complex nonlinear functions will help them predict Warfarin dosage accurately. They
have shown promise in this domain before, as noted in Section 2.2.2.
In this study, three different neural networks were trialled. The first, and simplest, of these,
had one hidden layer, whereas the second had two hidden layers. The third one had a much higher
‘momentum value’ than usual to try to alleviate the potential problem of reaching only a local
optimal solution, rather than a global optimum.
4.3.8 Fuzzy Lattice Reasoning (FLR)
Fuzzy Lattice Reasoning is a branch of ‘fuzzy logic’, which tries to make predictions based on the
premise that everything is a matter of degree. It hence tries to maintain levels of uncertainty with
respect to each candidate class for the current data. Theorems show that it can, in principle, be




However, this could not be used in those cases where nominal attributes were present because
it works by defining a scale between values, so that it can assign a probability distribution with
respect to a set of possible values. It hence needs numeric or ordinal values for all its attributes.
4.3.9 SMO
Support vector machines is a machine learning approach based on multiple regression, blending
this with instance-based learning. These select a small number of critical boundary instances for
each class and build functions to discriminate between the classes based on these. Non-linearity
can be learned as it first applies a non-linear “kernel” function to the attributes, and then a linear
solution based on these modified attributes is learned. Although initial training is often slow,
classification is generally sufficiently quick.
4.4 Attributes Used
The choice of which attributes to include for each dosage was not a straight-forward decision.
Theoretically, every previous dosage and INR reading could be used as attributes, but this is
obviously not desirable in that many of these would be irrelevant and perhaps even confounding
factors, computational and storage load would be heavy, and different size histories would be
difficult to compare. When selecting variables it must be remembered that variables that may
not add understanding in themselves can be useful if selected in combination with other variables.
Furthermore, combinations of variables may be useful in decreasing the number of attributes used.
Domain understanding is valuable in attribute selection (Guyon & Elisseeff 2003).
The attributes used aim to represent the patient’s history of Warfarin interaction, and thereby
implicitly represent those factors which influence the effect of Warfarin. Instead, partial instance
memory could be used, which would see only the most recent data points provided for algorithms
to learn on. However, it was decided that all data should be used, and attributes utilised as a
means of indicating relevance of previous data to the current data-point.
4.4.1 Global Attributes
Global attributes are those attributes which are constant for all data-points for a patient. They
are hence by definition only relevant for the learning approach where one machine has to use
data from all patients to train on. The only global attribute provided is the gender, which is not
actually known for all patients. This is specified as being either female, male or missing, and used
as an attribute when learning on multiple patient histories.
4.4.2 Representing the Temporal Nature of the Data
Many different combinations of attributes were trialled to represent the patient’s history before
a given data-point. It should first be realised that the points in a patient’s data set do not have
the same temporal gap. However, almost all are between 3-5 weeks apart, and the Warfarin from
a specific dose is virtually all exhumed from the body or processed in a week. In the interests
of simplicity the differences here were hence ignored. However, a patient’s history is being used
to represent implicitly not only constant attributes of the patient, such as their genetic makeup,
but also varying attributes such as diet and general lifestyle choices. This means that if two data
points are separated by a greater amount of time, there is more chance that there has been a
lifestyle change, and hence accuracy of prediction of the next data-point may be reduced.
The first type of attributes used was previous dosage and INR pairs. When learning from only
one patient’s data, up to three previous dosages and INR values were provided. More data was
provided when working with a training set based on multiple patients, with anywhere from one to
twelve previous dosages used. These extra data were provided here since the data set contained
multiple patient histories. The data may not therefore all be relevant, and hence may have lowered
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(a) This shows a data file built from data from
only this patient with an explicit ranking at-
tribute to show which data is more relevant
(b) This shows a data file built from data of multiple
patients, using a combination of previous data-points
and an average of a patient’s history
Figure 4.2: Sample data files used for training different algorithms
accuracy. It was hence hypothesised that increasing the number of attributes would, in providing
more information about a data-point, help to combat this.
When specifying a patient’s dosage, the amount of Warfarin prescribed over a week was used.
However, since only the total amount of Warfarin for the week was used, this meant that any
variance over the amount taken each day was ignored. This may in fact be of some importance.
Where the total weekly dosage varied, such as in the case of patients being prescribed differing
dosages on alternate days, an average weekly dose was used.
Previous INR values could be provided as either nominal or numeric values, and both were
trialled. Although the numeric value did give more information, if this did not ensure greater
accuracy then the simpler approach of using a nominal value would be preferred.
Average values of INR or dosage were also used when learning off multiple patient histories,
either alone or in conjunction with previous INR values and dosages. These averages were either
calculated over the total history or over a number of previous data-points.
When learning from only the patient’s own history, an explicit indicator of history was also
tried. This was achieved by dividing the history chronologically into a given number of parts,
and assigning each part a number such that the more recent dosages had a lower number. The
data-point to be predicted was given a value of ‘1’. The idea behind this was to explicitly tell the
algorithm which of the data-points upon which it was trained were more relevant, as the most
recent data-points would also have a value of ‘1’, and the largest numbers would correspond to
the oldest data-points in the history. Example data files, using different attributes, are shown in
Figure 4.2.
4.5 Evaluation Method
In this section we outline the steps undertaken for analysis of the different methods of predicting




The patient data used originated from the Christchurch Public Hospital, and was provided by Mr
David Shaw, a cardiothoracic surgeon. Although data for over 70 patients were initially provided,
not all of these could be used. Firstly, patients could be divided into two groups, namely initial-
state patients (within two years of their heart-valve operation) or steady-state patients. The
problem of predicting their response to Warfarin differs significantly between groups, and because
of the time constraints placed on this study it was decided to restrict it to steady-state patients
only. Some patients also had to be excluded because their history was of insufficient length.
Furthermore, for systems based on data from more than one patient, all patients studied had
to have the same therapeutic range. This is because nominal classification was used, and hence
a response to a particular Warfarin dosage was classified as low, in range or high. If the ranges
were different for different patients, these would cease to have any common meaning.
Data were originally provided in the form of photocopies of hand-written doctor notes, and
were manually entered into a spreadsheet before use. From this, ten patients were selected at
random on which to perform experiments. Dosages recorded are those given over a week.
4.5.2 Experimental Process
Once the data were in a spreadsheet, the data for those patients selected for further analysis
were extracted and converted into two files per patient, containing their INR history as nominal
and numeric values respectively. From here, scripts were written so that the spreadsheet data
could be converted to data files in the arff format required by the WEKA tool-bench, covering
all options of attributes detailed in Section 4.4. Following this, experiments were scripted to use
the candidate machine learning algorithms previously detailed in combination with the different
attributes and approaches available, and the success rates for each scheme collated. Prediction of
data-point values began on the seventh data point for each patient.
4.5.3 Comparisons Made
Because of the temporal nature of the data, for all but the ‘two layer’ approach, cross-validation
could not be used to judge the success of a particular algorithm. Cross-validation is typically
used as it trains the data set on a certain amount of the data, and then tries to predict the value
of the rest of the data. However, this would result in effectively using future data to predict
previous data-points. Instead, each different machine learning scheme was tested on each data
point individually, using only the patient history up to this point to train the algorithm. The
percentage of times that the algorithm correctly predicted the INR outcome as low, in range or
high, was used to denote the success rate of a particular machine learning scheme. To make
the data more meaningful, particularly in cases where one Warfarin prediction result was over-
represented in the data, all success rates were compared to a ‘base accuracy’. This calculated a
prediction based on the most likely event if no information was known about a data-point. The
reported success rate when comparing solutions can hence be represented as the gain (or loss) in
percentage accuracy over the base accuracy.
‘Two layer’ Approach
With the ‘two layer’ approach, however, the machine performing the final decision on the INR
outcome of a Warfarin dosage is learning only from the nominal INR values given to it by its
subsidiary machines. This means the temporal nature of the domain can be ignored when testing
this machine, and so cross-validation is able to be used.
For the purposes of this study, a particular form of cross-validation called ‘Leave-one-out’
cross-validation was used. This set the number of folds to the number of training instances, so the
classifier is built this number of times, each time using all but one of the data-points for training.
This last data-point is then tested. This makes maximum use of the available data and removes




Näıve Bayes is a statistical measure which is usually used as a benchmark for machine learning
studies. This calculates probabilistically the most likely class, based on the equation below.
P [H |E] =
P [E|H ]P [H ]
P [E]
P [H |E] is the probability of the hypothesis H occurring given that event E has occurred. Hence
the probabilities of the reading being in range, low or high can be calculated based on the attribute
values and what has previously occurred for these readings. However, it assumes independence of
attributes, something which is not the case for this domain. This classifier was used to see if the
more sophisticated machine learning algorithms provided any information gain over this simplistic
method.
The Physicians
In order to compare the results of our machine learning algorithms with those achieved by physi-
cians, it is assumed that the physicians are aiming to achieve an in-range INR value with every
Warfarin dosage prescribed. In this way, the number of times that the INR value was in fact in
range can be used as the number of times that the physician correctly predicted the resultant INR
value after a Warfarin dose.
Previous Research
The graphical nomogram detailed in Dalere’s (1999) study is to be used to predict the INR after
a particular Warfarin dosage, and this is to be converted to a nominal value depending on its
position relative to the target therapeutic index. The success rate of the graphical nomogram for





System Evaluation and Discussion
5.1 Different Machine Learning Approaches
5.1.1 Learning from an Individual History Only
Results from learning in this manner showed that different algorithms and attributes suited dif-
ferent patient histories. Table 5.1 corresponds each patient with the most successful algorithm in
predicting their history. Accuracies achieved varied from patient to patient, and a significant im-
provement could be noted over time for patients with long histories. For example, the accuracy for
patient 31 reached a maximum of 53% over the whole data-set, but when only the accuracy over the
last 12 data-points was considered, achieved 67%. The best performing algorithm and attributes
was not necessarily the same for these two situations, however. The best accuracy achieved by
each algorithm for each patient over the different parameters and attribute combinations trialled
is reported in Appendix A.
The first question that must be asked when examining the results above is if the application of
machine learning algorithms to a problem is in fact justified, or if a simpler model such as regression
would not work just as well. The data in this case are non-linear, as was discussed in Chapter 4
and hence multiple regression is really the only possibility beyond machine learning algorithms. In
fact, the SMO machine learning algorithm is basically an efficient way of implementing multiple
regression, so its success rate can be considered approximately representative of this. SMO proved
to be satisfactory for one patient. However, it is more interesting that the best machine learning
algorithm and attribute method did vary between patients, suggesting that there is no ‘one-fits-all’
solution. This is not surprising, considering the wide variability in patient response to Warfarin.
This would imply, however, that for every new patient different algorithms would have to be
trialled, before one that models the patient well is chosen. This also restricts the ability of any
system to accurately predict early values in a patient’s history.
The rules generated by the most successful algorithms may offer insight into the reactions of
individual patients to Warfarin. These get more complex as more data-points are provided on
which the algorithms can learn. However, some do not make intuitive sense and may be a result
of noise, such as those generated to model the data of patient 2, shown in full in Appendix B. For
this patient, a rule was formed by NNge stating that if the dosage is 14.0, the previous dosage is
also 14, and the previous INR reading is 3.2, then the current INR reading is predicted to be low.
Surprisingly, if all the same conditions hold with the previous INR reading of 3.1, then the current
INR reading is predicted to be high. Rules such as this lower the credibility of such solutions
in the eyes of physicians. It should also be noted that in order for the algorithm to predict an
‘in-range’ reading, it must have seen at least one example of this. For patient 2, eight data-points
were needed for training before the first such instance was encountered. This means that if the
algorithm was being used in reverse, to predict a dosage that would give an ‘in-range’ reading, it
would not have been able to do so until at least this point in the patient’s history.
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Patient ID Best algorithms Most predictive attributes Best accuracy
achieved





5 Neural network, IB3, IB5
and support machine
vectors (SMO)
Algorithm dependent, varied from
history grouping of different sizes
for SMO, history grouping in
groups of 5 for neural network, and
previous dosages and INR readings
(either nominal or real) for instance
based learning
82%








39 Neural Network Current dosage, attribute ranking
data-point by grouping history in
groups of 2 or 5
77%
40 Neural Network, SMO,
fuzzy lattice reasoning
(FLR) and NNge and
IBk
No attributes beyond the current
dose, and history grouping at-
tribute of various sizes (all but
IBk), or previous 3 dosages and real
INR values (all)
80%
44 Fuzzy Lattice Reasoning Attribute ranking data-point by





48 IB5 History grouped in groups of 3 70%
Table 5.1: Best algorithms when learning from an individual’s history
5.1.2 Learning from Multiple Histories
Again, the most predictive attributes and most accurate algorithm varied between patients. How-
ever, there was less variance here than for individual histories, as is seen in Table 5.2. A fuller
account, showing best accuracy achieved by each algorithm for each patient over the different
parameters and attribute combinations trialled, is reported in Appendix A.2. The success rate of
the best solution varied between 61% and 90%. Most patients did, however, need a larger history
than when trained on only their own data to enable an accurate prediction to be made. There was
also more consensus on the most successful algorithms, with Ridor, NNge and a Bayesian Network
formed by genetic search the most successful algorithms on more than one occasion each.
This is potentially a more useful solution, in that theoretically a patient does not need to have
an extensive history to make predictions. However, this would be most useful if it was the case
that the same algorithm could be applied to this same data to achieve accurate predictions for all
patients. This could not really be said to be the case, although only three algorithms featured as
optimal solutions for particular patients. In addition, the best results were usually obtained using
six to nine datapoints, either by taking the average of them, their specific values or a combination
of both. This means the patient would have to have to have a sufficiently large history before any
predictions could be made.
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Patient ID Best algorithms Most predictive attributes Best accuracy
achieved
2 Ridor Previous real INR value and
dosage, and average of each over
last 6 datapoints
80%
5 Bayesian Network with
Genetic Search
Previous six real INR values and
dosages and the average INR and
dosage
90%
31 Ridor Previous seven real INR values
and dosages, and average of each
over last 3 datapoints
71%
39 Ridor and NNge Previous three nominal INR val-
ues and dosages with the aver-
age of each over the last four dat-
apoints, and previous four real
INR values and dosages with the
average of each over the total his-
tory respectively
86%
40 Bayesian Network with
Genetic Search
Previous four real INR values and
dosages
83%
44 NNge Previous three doses and real
INR values, and average of each
over last 9 datapoints
61 %
48 NNge Previous real INR value and
dosage, and average of each over
last 9 datapoints
84%
Table 5.2: Best algorithms when learning from multiple patient histories
This could be improved by using an attribute, such as a nominal patient ID, to weight each
data-point in the training set in some fashion so those data-points belonging to the individual that
we are trying to predict for are given more importance. This may solve the problem noted that,
in some cases, data from other patients may in fact not be very helpful.
5.1.3 “Two Layer” Approach
The first important thing to note is the choice of algorithm with which to represent each patient
history in the first layer. Although in general the best performing algorithm and attributes were
chosen, if for a patient with a long history the best overall accuracy was not very high, such as in
the case of patient 31, the best performing solution over the last year was chosen instead.
Furthermore, in the case of patient 5, the Näıve Bayes approach was more successful than any
other algorithm, and hence this was used instead of a real machine learning solution to model this
patient.
Results from the two-layer approach were not as promising as initially hoped. Accuracies of
the best second-layer algorithm ranged from 44% to 85% depending on the patient. Possible
ways of improving it are discussed below. Many machine learning algorithms for the second layer
machine were trialled, yet the best result that could be achieved for a particular patient was
usually achieved by many different algorithms. This suggests that the choice of algorithm for this
second machine may not be so important. This has in fact been found to be generally the case
with stacking, so the second layer machine is usually chosen for simplicity (Wolpert 1992). The
results achieved by each second-layer algorithm for each patient are shown in Table 5.3. Where
different parameters were trialled for an algorithm, the best result achieved is recorded.
The two-layer approach was only moderately successful. In addition, it depends on individual
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Patient ID J48 Näıve Bayes SMO IBk Neural Network NNge Ridor RIPPER
2 45% 63% 54% 54% 63% 36% 63% 54%
5 81% 73% 81% 81% 81% 63% 81% 81%
31 39% 40% 31% 40% 33% 38% 39% 44%
39 85% 62% 54% 62% 54% 54% 46% 77%
40 80% 80% 80% 80% 80% 80% 80% 80%
44 38% 45% 42% 47% 42% 38% 35% 38%
48 57% 61% 65% 52% 57% 57% 43% 61%
Table 5.3: Performance of second-layer algorithms per patient for ‘two-layer’ approach
models being built for each patient. This means for new patients an algorithm will be trained
on their data as a component of the final solution. This may compromise the accuracy of early
solutions for a new patient, with the lack of their own data to train upon, but the use of data
from other patients should help compensate for this.
The choice of which algorithm to use for a first-layer machine modelling a particular patient
is also an interesting one, as the one which was most accurate over the whole data series for that
patient is not necessarily the optimal solution. Instead, a different solution, such as the most
accurate over the past year, may be a better option. Furthermore, although a static choice of
algorithm for the second-layer machine may be desirable from a simplicity point of view, this may
not be the most accurate solution.
The two-layer approach could be improved by making a finite number of first layer machines.
The data of new patients could then be incorporated into machines of a patient deemed sufficiently
similar, either through machine learning techniques or a manual decision. One reason for the lack
of accuracy of this approach might be that some of the machines predicting data for a patient
were irrelevant, and hence confusing, for a particular patient. Some sort of filtering could hence
be done to restrict the first-layer machines to only those that truly help, such as picking the best
n machines based on their accuracy over the last k data-points.
In addition, to help the second layer machine make its decision, the gender of patients used to
train each first layer machine could be given with the prediction of each first layer machine.
An analysis of the rules generated by the most successful second layer machine algorithms is
also interesting. For patient 39, the two-layer approach was more successful than when learning
on its own history, with an 85% success rate. The algorithm to achieve this result was J4.8, and
the resulting tree was, surprisingly, based entirely on the predictions of the machine that learned
to model the history of patient 5. The rules dictated that if machine 5 predicted it to be low, it
would be in range; if it predicted it in range, it would be high; and if it predicted it high it would
be in range. This does not, however, allow any predictions of a low reading. The success here
may be because of the high prediction rates achieved by most of the machine learning solutions
for patient five.
The 82% result for patient 5 is also less useful when it is examined more closely. Any rule-
based algorithm that achieved this success rate did so by learning the rule that patient 5 is always
above range. This is clearly not a useful rule in our domain, as it is possible for every patient
to be brought into the therapeutic index. However, the instance-based approaches also achieved
this accuracy, and they may be able to better model low and in-range doses as well. Most of the
algorithms for patient 40 also came up with single rules classifying everything as above range.
NNge, however, came up with potentially more sensible rules and achieved the same accuracy, as
shown in Table 5.4.
5.2 Attribute Selection
The most helpful attributes differed depending on each machine learning algorithm, the individual
patient and the scheme employed. However, it seems that when learning on multiple histories,
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Prediction First-layer machine prediction
2 5 31 39 40 44 48
HIGH any {LOW, HIGH} {HIGH} {IN, HIGH} {HIGH} {HIGH} {IN, HIGH}
IN {HIGH} {LOW} {HIGH} {LOW} {HIGH} {LOW} {LOW}
Table 5.4: Rules generated by NNge for patient 40, Two-layer scheme
a longer history is required, but still no longer than nine data-points, roughly equivalent to nine
months for most patients. When learning on an individual’s history, the use of only an attribute
that ranked the data-points in terms of which were the most useful (recent) data-points was more
successful than explicitly specifying previous dosages in some cases.
It must also be remembered that increasing the number of dosages required as attributes,
either as a specific value or averaged together, also decreases the number of datapoints on which
training and testing can take place. For example, the seventh datapoint can be predicted by a
scheme based on only the four previous dosages, but not by one dependent on the eight previous
dosages. This means that schemes requiring more attributes may be unfairly advantaged as their
accuracy is calculated over less datapoints. In addition, these are later datapoints in the history
so the scheme is learning from more data, even if it is not learning off more datapoints.
Where the choice of the best algorithm for an individual patient was uncertain, the performance
of the last six to twelve was sometimes looked at. This was firstly done when the size of the history
ensured that all attribute combinations would be possible for all of these datapoints, so a fair
comparison over the same number of datapoints could be made. In addition, looking at the more
recent datapoints shows the algorithms’ most recent performances, after they have had plenty of
data on which to learn. The algorithms performing well here are hence the algorithms that have
been able to sufficiently model the entire patient history.
The representation of INR values was varied between real and nominal values. In most cases,
it did not seem the extra information provided by real values was capitalised on by the machine
learning systems for extra predictive power. Table 5.5 shows the success rates for each algorithm
when trained on data-points with between one to three previous dosages for patient 48, in order to
show the comparative performance of using nominal and real INR values. As previously discussed
in Chapter 4, Section 4.3.8, FLR can only be performed when real INR values are used.
Algorithm 1 previous dose 2 previous doses 3 previous doses
Nominal Real Nominal Real Nominal Real
Bayesian Network 48% 48% 48% 43% 48% 39%
Neural Network 52% 57% 57% 52% 65% 57%
SMO 57% 57% 61% 52% 65% 57%
IBk 52% 52% 57% 48% 48% 48%
NNge 52% 43% 61% 35% 48% 43%
Ridor 43% 39% 48% 43% 43% 57%
J4.8 43% 43% 43% 43% 43% 48%
Table 5.5: Success rates when using nominal or real INR values to represent own patient history
(patient 48)
One might have expected that with more attributes, or previous data, given to the machine,
accuracy would only increase. However, this is not the case. Although to a certain extent adding
several more attributes does help, too long a history can be a hindrance. This may be because
older data-points are in fact mostly irrelevant, with large lifestyle changes having occurred since.
A typical example of this is shown in Table 5.6, where for patient 31 the change in accuracy
rate over different numbers of previous data-points when learning on multiple histories is shown.
Previous INR values here are represented as nominal values. One should also note the non-linearity
in performance as the number of previous dosages used increase. This is typical when machine
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learning parameters are modified because of stochastic effects.
Algorithm Number of previous dosages as attributes
1 2 3 4 5 6 7 8 9
Bayesian Network 41% 45% 45% 49% 44% 45% 39% 41% 46%
Neural Network 42% 44% 40% 41% 43% 39% 41% 45% 29%
SMO 49% 48% 51% 52% 50% 45% 47% 49% 51%
IBk 42% 47% 44% 45% 42% 37% 39% 46% 37%
NNge 45% 42% 48% 40% 35% 35% 34% 36% 44%
Ridor 38% 33% 36% 34% 33% 30% 37% 36% 40%
J4.8 36% 41% 38% 38% 29% 31% 31% 33% 29%
Table 5.6: Accuracy of different algorithms when increasing number of previous data-points used
(learning on multiple histories, patient 31)
5.3 Comparative Analysis
Comparisons were made between different ways of predicting the effect of a given Warfarin dosage
by examining the percentage of correct predictions made over the datapoints. However, predictions
are only made from at least the 7th data-point, and on some occasions slightly later than this, if
the attributes required dictate this. This allows sufficient history to be used to make predictions.
Table 5.7 shows a comparison of the best machine learning solutions with graphical nomograms,
the accuracy of the physician and a Näıve Bayesian prediction. The machine learning solutions
compared are the best algorithm combination when learning on the patient’s own history, the best
when learning on multiple histories, and the best two-layer result obtained. Further information
on the rationale for a comparison with Näıve Bayes in particular was provided in Chapter 4,
Section 4.5.3. The ‘base accuracy’ to which each solution is compared is the percentage of the
most popular class over the patient’s history, or the accuracy that would be achieved if the most
common result was predicted in every case.













2 10 17 0 -18 0 4
5 0 8 0 -19 -64 9
31 5 23 -4 -8 0 -4
39 23 32 31 7 0 15
40 0 3 0 -20 -60 -13
44 13 19 5 3 -9 12
48 22 36 17 4 0 17
Table 5.7: Comparison of the success in predicting the effect of Warfarin dosages of the best
solution for each approach
One-way ANOVA was performed on the raw percentage success for each patient of the five
different prediction methods. A significant difference was found (F5,36 = 7.198, p < 0.001 ).
Post-hoc analysis using paired t-tests with a Bonferroni correction1 was hence applied. This
showed a weakly significant difference between Näıve Bayes and the machine learning solutions,
apart from the case of the two layer approach from which Näıve Bayes was not significantly
different. There was a weakly significant difference in accuracy between the two-layer approach,
1At the 5% level the Bonferroni value is calculated as 0.05/number of tests, which is 15 in this case
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with a mean accuracy of 66.5%, and the nomogram, with a mean accuracy of 52.5%:t6 = 4.5, p =
0.0041. More crucially, strongly significant differences were observed between the machine learning
solution learning only the individual’s history, achieving a mean best success rate of 70%, and the
nomogram’s accuracy (52%): t6 = 8.17, p < 0.001. There was also a significant difference between
the machine learning solutions learning on the patient’s own history and that learning on multiple
patients, which achieved a mean accuracy of 79%: t6 = 4.8, p = 0.0029. When learning on the
history of multiple patients, the best machine learning solution was significantly superior to both
the nomogram (t6 = 11.2, p < 0.0001) and the doctors’ accuracy (41%): t6 = 4.94, p = 0.0026.
Although a comparative analysis does make the machine learning approaches look promising,
particularly that built on multiple patient data, some reservations must be mentioned. Most
importantly, this was a study based on pre-existing data. This means that the machine learning
algorithms were not having to cope with keeping the patients in range. This meant for some
patients there were very few examples of a particular type. For example, patient 5 was the easiest
for the machine learning algorithms to correctly predict, but this was most likely because most of
the readings for that patient were high. This means the machine learning solutions, in most cases,
did not learn the effect of Warfarin on this patient as such, but merely that for this patient the
response to Warfarin was likely to put them above range. This is clearly not so useful in a clinical
situation where a dosage is desired that will put the patient in range.
Other factors that should be remembered include that experiments were not performed on a
large number of patients. Furthermore, the physician for each patient was not necessarily the
same, and a lack of experience of some could result in worse performances than is typical.
5.3.1 Confounding factors
Some sources of noise must be considered when examining these results. However, these affect the
original data and are not part of machine learning experiments performed on the data. These hence
only affect overall accuracies obtained, and should not have much, if any, effect on a comparative
analysis.
Such noise can be caused by dramatic dietary or other lifestyle changes, or bleeding events,
illness, noncompliance, or medicine changes. Another significant problem is that the INR reading
itself is not always accurate, with a standard deviation of 0.2 observed (Gage et al. 2000).
There is, however, one effect of noise that must be considered when comparing the accuracy of
a physician to that of machine learning. This is that the physician may be able to more accurately
specify something as a result of noise by discussion with the patient after an unusual result. Gage
et al. (2000) recommend that if the INR values for a patient have been previously stable, and the
latest INR value is more than 0.2 below or 0.4 above the therapeutic index, then the source of
such a difference be investigated. If none can be found, then the dosage should be changed, but
the next INR reading appointment made sooner than it would be otherwise. It would be desirable
for any end solution system to ask a physician, after a surprising reading, if any reason for this is
immediately obvious. This may enhance its accuracy, as it would be able to assign less importance
to this data-point when making later predictions. An end-system in a clinic would also want to
deal with rescheduling the next appointment of a patient following such an event.
It should be mentioned also that for the purposes of this study, the percentage of in-range INR
readings is used for comparative purposes. However, other methods are possible. The recommen-
dation by Azar, Deckers, Rosendaal, van Bergen, van der Meer, Jonker & Briet (1994) is that
the percentage of total observation time spent in range, assuming INR changing linearly between
readings, should be taken as a means of comparison. However, the INR reading may not in fact
change in a linear fashion, especially in the case of steady-state patients where INR readings are






In this research, machine learning systems outperformed traditional solutions with regards to
predicting the effect on a given individual of a particular Warfarin dosage. This study has hence
given hope to the idea that a machine learning approach to Warfarin could indeed be valuable in
helping doctors to prescribe accurate Warfarin dosage regimens. Although the lack of clinical trials
means that it cannot be emphatically stated that the best machine learning solution outstripped
the performance of physicians, it does seem that the ability of the best solution for each patient
to predict the INR reading was superior to that of the patients’ physicians. It seems likely that a
system could be built that could use this predictive ability to prescribe an optimum Warfarin dose.
Such a system would indeed be a valuable asset, not only to physicians but also in contributing to
the viability of patient self-management of their Warfarin regime. This would improve the quality
of life for such patients.
Best results were obtained by the machine learning approach involving learning on data from
all patients. This is also useful in that it may be able to be used on patients with a short history,
as plenty of data from other patients are available. However, the precise algorithm and attributes
to be used for best results varied between patients, although Ridor, NNge or a Bayesian network
generated by genetic search were usually the most successful.
The ‘two layer’ approach, a novel contribution to this problem of multiple, hypothetically
related temporal datasets, did not prove to be as successful as initially hoped. However, improve-
ments may help these become more useful, as discussed in Chapter 5, Section 5.1.3.
Further research would be useful to try and improve the results found in this study, and clinical
trials would be a necessity before any certain conclusions about the true viability of a machine
learning solution to Warfarin prescription can be made.
6.1 Future Research
Future research could take two main directions. The first would relate to the Warfarin problem
directly. Most importantly, one could investigate ways to convert the current prediction of the
effect of a dosage into a recommendation of what dosage to give. One solution would be to use
the midpoint of all dosage values that the solution predicts will end up in range, but this may not
prove to be the best.
Further work could also look at various ways to improve accuracy, including other ensemble
approaches. “Bagging” is commonly used, and sees multiple machines learning on different random
subsets of the data, and then voting on the outcome of a class. This is similar to what has
actually been implemented in the ‘two layer’ approach during the course of this research, except
that bagging would see the data for each machine come from the same data-set and be randomly
chosen. Bagging is effective in many domains, but usually gives only a modest improvement in
accuracy. “Boosting”, on the other hand, where misclassified instances are given greater weight
and the machine re-trained on them, is less likely to work, but when it does it usually produces
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a greater improvement than does bagging (Bauer & Kohavi 1999). However, boosting is unlikely
to assist the Warfarin problem in that boosting is badly affected by noise, as it assigns more
importance to unusual instances. Such instances are often ‘noisy’ and the extra weight thus
placed on them is hence usually undesirable.
The accuracy over early data-points for a patient could also be examined in more detail,
comparing the ability of machine learning solutions to predict the effect of a Warfarin dose with
little history for a particular patient. This could be applied not only to the early history of steady-
state patients, but also to unstable patients in their first few months of Warfarin treatment. This
is particularly important, since it is difficult for physicians to accurately prescribe Warfarin at this
time, as well as more dangerous for the patients.
More detailed research on other time-series machine learning methods and their application
to the Warfarin problem could also be performed, especially with the case of Hidden Markov
Models, which were mentioned in Section 2.1, Chapter 2. Some parameter fine-tuning to the
methods implemented in this study could also be worthwhile. Genetic algorithms were also not
fully explored in the context of this study, with genetic search being restricted to finding an optimal
Bayesian network only.
Initial state patients would also be another interesting area to study, as they are usually harder
to keep within their therapeutic index than their steady-state counterparts.
Extensions to the advice that an end-system is capable of giving could also be researched, such
as how much vitamin K to prescribe to patients who are suffering a bleed.
The other main direction in which this work could be taken is that of time-series research. The
algorithms and attributes useful here could be trialled in other domains. It would be interesting
to apply the two-layer approach, in particular, to another domain with multiple related data-
sets. Examples of this could include domains as diverse as predicting seismic activity looking at
a number of different volcanoes and their activity over time, to the price of shares of the same
industry over time. Other medical applications are also numerous.
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Appendix A
Best Algorithm Results by Patient
A.1 Learning on individual history only
Patient ID Näıve Bayes Bayesian Network Neural Network SMO IBk FLR NNge Ridor J48
2 67% 73% 67% 67% 64% 45% 73% 50% 67%
5 91% 73% 82% 82% 82% 73% 73% 73% 45%
31 44% 44% 53% 51% 47% 42% 49% 51% 51%
40 60% 60% 80% 80% 80% 80% 80% 60% 60%
48 57% 52% 65% 65% 70% 57% 61% 65% 57%
39 69% 54% 77% 62% 62% 54% 69% 62% 69%
44 52% 48% 48% 45% 53% 55% 53% 53% 52%
Attributes trialled:
• Current dosage, and a ‘ranking’ attribute that ranks data in terms of how recent it is, in
groups of size n, where n varied from 1 to 10
• Current dosage provided only
• Current dosage, and previous k data-points where k varied from 1 to 3
INR values were represented in both a nominal and real fashion.
A.2 Learning on multiple histories
Patient ID Näıve Bayes Bayesian Network Neural Network SMO IBk NNge Ridor J48
2 70% 78% 67% 67% 71% 73% 80% 78%
5 88% 90% 88% 78% 78% 78% 83% 75%
31 53% 50% 56% 55% 50% 53% 71% 60%
40 67% 83% 80% 67% 75% 75% 75% 67%
44 55% 48% 54% 51% 55% 61% 50% 53%
48 65% 67% 63% 64% 75% 84% 74% 58%
39 57% 83% 83% 83% 83% 86% 86% 78%
Attributes trialled:
• Current dosage and previous n data-points where n varied from 1 to 9
• Current dosage and average over k data-points where k varied from 1 to 9
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A.2. LEARNING ON MULTIPLE HISTORIES
• Current dosage and average over the total history
• Current dosage and combinations of the previous n data-points with the average over k
datapoints




B.1 Rules for best individual solution for patient 2
Note that these rules, generated by the NNge algorithm, may not cover all possible values of input,
in which case the ‘closest’ rule is applied. History size is the number of data-points on which the
algorithm has been trained.
Size of history Prediction Current Dosage Previous Dosage Previous INR
5 HIGH 14 ≤ dosage ≤ 35 28 ≤ dosage ≤ 35 3.4 ≤ INR ≤ 5.8
14 14 3.1
LOW 14 14 3.2
6 HIGH 14 ≤ dosage ≤ 35 28 ≤ dosage ≤ 35 3.4 ≤ INR ≤ 5.8
14 14 3.1
LOW 14 14 3.2
14 14 1.3
7 HIGH 14 ≤ dosage ≤ 35 28 ≤ dosage ≤ 35 3.4 ≤ INR ≤ 5.8
14 14 3.1
LOW 14 14 3.2
14 14 1.3
IN 21 14 1.4
8 HIGH 14 ≤ dosage ≤ 35 28 ≤ dosage ≤ 35 3.4 ≤ INR ≤ 5.8
14 14 3.1
LOW 14 14 3.2
14 14 1.3
IN 21 14 ≤ dosage ≤ 21 1.4 ≤ INR ≤ 2.1
9 HIGH 14 ≤ dosage ≤ 35 28 ≤ dosage ≤ 35 3.4 ≤ INR ≤ 5.8
14 14 3.1
LOW 14 14 3.2
14 14 1.3
IN 21 14 ≤ dosage ≤ 21 1.4 ≤ INR ≤ 2.2
10 HIGH 14 ≤ dosage ≤ 35 28 ≤ dosage ≤ 35 3.4 ≤ INR ≤ 5.8
14 14 3.1
LOW 14 14 3.2
14 14 1.3
21 21 2.3
IN 21 14 ≤ dosage ≤ 21 1.4 ≤ INR ≤ 2.2
11 No change
12 No change
13 HIGH 14 ≤ dosage ≤ 35 28 ≤ dosage ≤ 35 3.4 ≤ INR ≤ 5.8
14 14 3.1
43
B.1. RULES FOR BEST INDIVIDUAL SOLUTION FOR PATIENT 2
LOW 14 14 3.2
14 14 1.3
21 21 2.3 ≤ INR ≤ 2.5
IN 21 14 ≤ dosage ≤ 21 1.4 ≤ INR ≤ 2.2
14 No change
15 No change
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